Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart-Reference-Cited by-同舟云学术

Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart

Published:2016-05-24 Issue:9 Volume:30 Page:3069-3082
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Huang Xi‐Ping¹,Ludke Ana¹,Dhingra Sanjiv²,Guo Jian¹,Sun Zhuo¹,Zhang Li²,Weisel Richard D.¹³,Li Ren‐Ke¹⁴

Affiliation:

1. Division of Cardiovascular SurgeryToronto General Research InstituteUniversity Health Network Toronto Ontario Canada

2. Department of PhysiologyUniversity of Manitoba Winnipeg Manitoba Canada

3. Department of Pathobiology and ImmunologyUniversity of Toronto Toronto Ontario Canada

4. Division of Cardiac SurgeryDepartment of SurgeryUniversity of Toronto Toronto Ontario Canada

Funder

Canadian Institutes of Health Research

Heart and Stroke Foundation of Canada

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201600331R

Reference26 articles.

1. Cell Therapy for Heart Failure

2. Heart regeneration

3. Manifestations and mechanisms of stem cell aging

4. Use of Mesenchymal Stem Cells for Therapy of Cardiac Disease

5. Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The composite biomatrix SC/CM improved the therapeutic effects of xenogeneic MSC on wound healing in immune-competent mice via immune niche reprogramming;Journal of Materials Science;2024-08

2. Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer;Nature Communications;2024-07-18

3. Unveiling the immunomodulatory shift: Epithelial-mesenchymal transition Alters immune mechanisms of amniotic epithelial cells;iScience;2023-09

4. MHC Class I Enables MSCs to Evade NK-Cell–Mediated Cytotoxicity and Exert Immunosuppressive Activity;Stem Cells;2022-07-19

5. IITZ-01 activates NLRP3 inflammasome by inducing mitochondrial damage;JUSTC;2022